Vivani Medical, Inc. (VANI) - Form 8-K Summary
Business Context and Reporting Period
Vivani Medical, Inc., a Delaware corporation, filed this Current Report on Form 8-K on March 26, 2026. The filing serves to announce the issuance of a press release regarding the Company's financial results and business update.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached press release (Exhibit 99.1) but are not detailed in the body of this 8-K document.
Material Changes
No specific material changes versus prior periods are quantified in this filing. The document references a press release covering Fourth Quarter and Full Year results, though the text contains conflicting references to the years 2024 and 2025 within the exhibit description.
Guidance, Outlook, and Risks
The filing indicates that management provided a "Business Update" in the attached press release. However, specific guidance, outlook figures, risk factors, contingencies, or unusual items are not disclosed in the text of this 8-K. The information in Item 2.02 and Exhibit 99.1 is explicitly stated as not being "filed" for purposes of Section 18 of the Exchange Act.
Key Facts for Investor Verification
- Verify the correct reporting period (2024 vs. 2025) by reviewing the attached Exhibit 99.1 press release, as the 8-K text contains conflicting year references.
- Review the full press release for actual financial figures, as this 8-K only announces the release without providing data.
- Note that the financial information in the press release is not incorporated by reference into this filing for liability purposes under Section 18 of the Exchange Act.
- Confirm the trading symbol "VANI" on The Nasdaq Capital Market.